Abstract: The aim of this exploratory study was to examine the possible mechanisms of behavioral change in a cognitive-behavioral intervention supporting medication adherence in HIV-infected persons. A total of 60 persons currently under medical treatment were randomized to psychotherapy or usual care and were compared with a sociodemographically matched group of general psychotherapy clients. Outcome measures included therapy adherence using medication event-monitoring system psychotherapeutic processes and changes of experience and behavior. The general psychotherapy group was initially more distressed than HIV psychotherapy patients and reached higher levels of psychotherapeutic effect. In the HIV psychotherapy patients, a significant effect was found for maintaining adherence to medical treatment (Weber et al., 2004) . These findings show that psychotherapy is a beneficial intervention for HIV-infected persons, and therapeutic alliance and activation of resources do not differ from a general psychotherapy treatment. Differential effects were detected for specific process variables, namely problem actuation. 
Maintaining adherence is one of the major challenges in HIV-infected patients (Paterson et al., 2000) . Viral resistance can develop when drug levels are insufficient to stop viral replication completely. Drug resistance may lead to clinical progression in the individual, and resistant organisms can be transmitted to other persons. Yet adherence to drug therapy for a chronic and incurable illness is demanding for patients.
The World Health Organization has launched a campaign to promote therapy adherence in the treatment of chronic diseases (Sabaté, 2003) . Definitions of adherence following Bissonnette (2008) have been conceptualized in different ways among the disciplines of medicine, psychology, and pharmacy. In the case of HIV-infected participants, the medical approach has been taken. It is highly important for participants to meticulously follow the instructions of the pharmacological treatment. Thus, the focus of the psychological intervention has to be on difficulties or personal barriers in order to improve adherence to therapy.
Numerous predictors of adherence have been recognized, including physicianÁpatient communication, organizational aspects of care settings, patient characteristics (e.g., emotional issues, health status, sociodemographic and behavioral variables, and recreational drug use), mode of drug regimen (e.g., number of pills, dosing frequency; Nieuwkerk & Oort, 2005) , and adverse treatment events such as side effect severity (Mannheimer, Friedland, Matts, Child, & Chesney, 2002; Turner, 2002) . In particular, depression, self-efficacy, and social support were shown to distinguish between good and poor adherence (Catz, Kelly, Bogart, Benotsch, & McAuliffe, 2000) . Maintaining long-term treatment can be particularly challenging when the treatment course develops other than as expected, adverse blood results occur, or patients suffer from other side effects of the treatment. We assume that the fundamental precondition for maintenance of drug therapy is the patient's motivation and his or her readiness for a behavior change (Prochaska, DiClemente, & Norcross, 1992; Weber et al., 2004) .
The impact of social support on enhancing quality of life and adherence to medication in HIV-infected persons has been investigated already (Gonzalez et al., 2004; Simoni, Frick, Lockhart, & Liebovitz, 2002) . However, only scant support for specific interventions has been found (Fogarty et al., 2002; Haddad et al., 2000; Haynes, McDonald, Garg, & Montague, 2002; Haynes, McKibbon, & Kanani, 1996; . Recently published data have shown some effects of group cognitiveÁbehavioral therapy (CBT) on changes in risk behavior (Kalichman, Rompa, & Cage, 2005) , depressive symptoms, and social support (Carrico, Antoni, Weaver, Lechner, & Schneiderman, 2005) and modest effects on adherence (Wagner et al., 2006) : First results of an individual psychotherapy intervention showed significant effects on adherence, as discussed in Weber et al. (2004) . No data exist on meaningful factors or combination psychotherapy for successful behavior change. A better understanding of these factors could even help to maintain or enhance medication adherence among persons who do not seek psychotherapy. Additionally, knowledge of how such intervention differing from a psychotherapeutic process seems to be important in terms of treatment improvements in HIV patients.
In general, psychotherapy to support behavior change is based on several general principles. Grawe (1997 Grawe ( , 2004b ) postulated four research-informed mechanisms of change: mastery/coping, clarification of meaning, problem actuation, and resource activation. All of these mechanisms of change might be linked to outcome and be dependent on distinctly different psychotherapeutic goals (i.e., supporting adherence to therapy for HIV-infected persons vs. reducing psychopathology in individuals receiving outpatient psychotherapy).
In the first proposed mechanism of change* mastery/coping*the patient and therapist approach the problem in terms of ability. Therapeutic skills and an appropriate understanding of the patient's problem are essential for progress. In the second mechanism*clarification of meaning*feelings (following Lazarus's, 1991, appraisal theory of emotion) are changed by approaching whatever the patient sees as a threat to a personal goal in terms of its motivational components (i.e., approach vs. avoidance). Clarifying the meaning of a specific situation or altering the importance of a personal goal may change the patient's feelings dramatically (Greenberg, Rice, & Elliott, 1996) . The third proposed mechanism of behavior change is problem actuation, which is based on the insight that automated behavior and perception can be changed only by activating the neural foundation, that is, by experiencing avoided situations. The fourth, and possibly the most important, factor in effecting change are the patient's own resources; psychotherapy can only work with what the patient brings into therapy. Resources such as strong motivation, social resources, verbal capacity, and imagination are necessary ingredients for therapeutic change (Gassmann, 2002) .
Within this framework, the objectives of our 1-year randomized trial were twofold: (a) to study patients' reported changes in experience and behavior and investigate the mechanisms of behavior change linked to maintenance of adherence, and (b) to compare the doseÁeffect relationship for the proposed mechanisms of change in the HIV psychotherapy group and an age-and gender-matched sample of psychotherapy patients in an outpatient setting (general psychotherapy group).
Materials and Method

Participants
HIV-infected patients. Of 60 randomized HIVinfected persons originally recruited, we were able to analyze data from 53. Seven patients did not finish the trial. One patient was erroneously randomized, five dropped out during the study, and one died (unrelated to the study). The final sample included 43 men (81.1%) and 10 women (18.9%) ranging in age from 25 to 71 years (M 044.3, SD 010.7). Twenty-nine were allocated to the standard of care plus psychotherapy group (HIV psychotherapy group), including 21 men (72.4%) and eight women (27.6%) ranging in age ranged from 25 to 71 years (M 044.8, SD 011.1). One participant did not complete the questionnaires. Twenty-four participants were allocated to the standard-of-care control group (HIV control group), including 22 men (91.7%) and 2 women (8.3%) ranging in age from 31 to 65 years (M 043.7, SD 010.5). The allocation schedule for the two treatment arms and three different CD4 strata (0Á0.05 )10 9 /l, 0.051Á0.2 ) 10 9 /l, or !0.2 )10 9 /l), with randomly permuted block sizes of two and four, was generated in advance with the program RANCODE V 3.0 (IDV Datenanalyse und Versuchsplanung, Gauting, Germany) and properly concealed from care providers. CD4 is an indicator of the degree of HIV infection and was used in this study to stratify the treatment arms. CD4 is a primary receptor used by HIV-1 to gain entry into host T cells.
General psychotherapy patients. A group of 28 patients from a psychotherapeutic ambulatory facility (outpatient clinic of the University of Bern, Switzerland) matched on sociodemographic factors (age and gender) formed a comparison group for the intervention arm of the HIV-infected persons (psychotherapy). The participants in this group suffered from a variety of psychopathological disorders, mainly anxiety disorders (Â50%) and depression (Â30%). In contrast to the HIV group, members of the comparison group had chosen psychotherapeutic treatment of their own accord or had been recommended for psychotherapy by health authorities. The participants of this group included 21 men and seven women ranging in age from 31 to 62 years (M 040.6, SD 07.9). The mean number of sessions for members of the comparison group was 33.2 (SD 017.3, range 11Á77).
In the beginning, members of the general psychotherapy group had higher levels of distress (M 0 1.03, SD 00.52) than the HIV psychotherapy group, as measured with the Symptom Checklist-90-Revised (SCL-90-R) Global Severity Index (GSI). The mean pretreatment GSI was 0.55 (SD 00.39) for participants receiving psychotherapy (N 029) and 0.42 (SD 00.47) for controls (N 024). There was no posttreatment (i.e., after 12 months) difference between groups. Goal attainment scaling was used to identify personal therapeutic goals in the HIV-infected group as well as in the matched general psychotherapy group. For the HIV intervention group the principal therapeutic goal was adherence to therapy. This principal goal had to be the main focus of their therapeutic intervention. Additional individual goals might have been formulated individually. In contrast, for the matched general psychotherapy group, the principal outcomes were assessed individually in terms of each person's major complaint without any restrictions in terms of treatment goals.
Therapists
Intervention was provided by licensed psychotherapists in private practice. All of them had formal training in CBT, had heard a 2-hr lecture on antiretroviral therapy before the study, and were instructed to focus on the maintenance of antiretroviral drug adherence. They were free to work as they saw fit on any other problem the patient presented to them. The sessions were all tape-recorded and psychotherapists were closely supervised.
Design
We conducted a prospective, controlled 12-month trial with 60 HIV-infected persons on antiretroviral combination therapy who were 1:1 randomized to receive standard of care or standard of care plus individual cognitiveÁbehavioral intervention provided by psychotherapists. Study design and patient selection have been described elsewhere (Weber et al., 2004) . Inclusion criteria were as follows: antiretroviral therapy containing a combination of at least three different drugs of at least two different drug classes, viral load below 50 copies/ml, participation in the Swiss HIV cohort study, and no intravenous drug use (or, in case of drug addiction, on stable methadone maintenance). Ethics committee approval was obtained, and all participants gave written informed consent. Standard of care and study consultations of each patient were provided by the same physician at the University Hospital HIV outpatient clinic in Zurich, Switzerland. After randomization, participants in the intervention arm received the address of one of the psychotherapists and were asked to schedule a first appointment. The allocation of participants to psychotherapists was random, based on the number of participants each psychotherapist indicated before the start of the study that they would care for. The study protocol specified a minimum of three and a maximum of 25 sessions within the 1-year study period. Within these bounds, appointment frequency was worked out by participants and psychotherapists during the course of the study. Intervention sessions lasted 45 min on average. The mean number of sessions per participant was 12.8 (SD 06.8). Participants were informed that the intervention was not proposed to address a psychological problem or psychiatric disease but rather to support adherence to drug therapy using CBT.
Psychotherapists were instructed to define at first visit, together with the participants, at least two goals for future intervention. At least one of these goals had to be related to adherence to antiretroviral therapy, but participants and psychotherapists were free to identify additional goals not related to HIV therapy. Interventions had to be based on concepts of CBT (Bandura, 1977) .
Measures
Adherence measure. Medication intake in the intervention and control groups was assessed using the eDEM medication event-monitoring system (Aardex Ltd., Zug, Switzerland; Cramer, Mattson, Prevey, Scheyer, & Quellette, 1989) . The study nurse working closely with the physician downloaded the monitoring data monthly to a central database in the presence of the participants, who saw their own performance on screen as a graphic, depicting times at which pillboxes were opened during the previous month. We used the measurements for the first month of the study to approximate baseline values.
Psychosocial measures. The German translation of Derogatis's SCL-90-R (Franke, 1995) , a structured and standardized questionnaire, was used at Psychotherapy and adherence to anti-HIV therapy 205 baseline and at 12 months to screen for nine symptoms of psychopathology (e.g., depression, anxiety) and to measure GSI, intensity of symptoms, and number of self-reported symptoms. Baseline measurements from these instruments were evaluated using a computer program and the results transferred at once to the appropriate psychotherapists. Compared with a group of healthy individuals (Franke, 1995) , mean GSI was slightly higher in our HIV group; however, mean values were lower than in a comparable group of HIV-infected persons (Franke, Jäger, & Stäcker, 1995) . Psychometrically, the SCL-90-R showed excellent reliability in the HIV sample (Cronbach's a0.94).
The structured and standardized questionnaire Veränderungsfragebogen des Erlebens und Verhaltens (VEV-VW; Zielke & Kopf-Mehnert, 1978; Willutzki, 1999 ) was used at 6 and 12 months to assess changes of experience and behavior as perceived by participants themselves. The questionnaire consisted originally of 27 bipolar items that are answered on a 7-point Likert scale (e.g., ''I am more relaxed'' vs. ''I am more tense''). The total score is indicative of ''quietness, confidence, optimism'' versus ''stress, uncertainty, pessimism'' (Weber et al., 2004) . For the present study, the VEV questionnaire was reduced to 17 items. Psychometrically, the shortened VEV showed excellent reliability in the HIV sample (Cronbach's a 0.96).
Therapy process assessment. Psychotherapists kept a record on qualitative information and used goal attainment scaling (Kiresuk & Lund, 1978) to identify intervention goals. Therapeutic process was assessed by a theory-driven postsession report (Regli & Grawe, 2000) completed by therapists and patients independently. Items on the postsession report were formulated according to the four postulated mechanisms of change (Grawe, 1997) . Additional items examined progress made during the session.
An example item in the mastery/coping category for patients is ''I feel competent in situations I didn't feel competent in until now.'' The same category was rated by the therapists in response to such items as ''Today, I have actively worked on helping the patient to cope with situations that are difficult for him or her to handle.'' Reliabilities of patient and therapist scales differed greatly. Cronbach's a ranged from .16 to .77 for patients and from .26 to .93 for therapists. Because both patients and therapists focused on the same change mechanisms, we built a single scale using the two perspectives. For reliabilities of the combined scales, see Table I .
For patients, clarification of meaning included such items as ''Today possible solutions for my problems (fulfillment of wishes, reaching my goals) have been clarified.'' For therapists, a typical item was ''I have actively aimed at helping the patient to see new connections in relation to his or her problems (needs and goals).'' For patients, problem actuation included such items as ''What we covered in today's session was at times very unpleasant.'' For therapists, a typical item was ''Today I aimed deliberately at involving the patient's feelings.'' Patient resource activation items included, for example, ''Right now I feel supported by the therapist in the way I like to be.'' For therapists, a typical item was ''In today's session I have actively tried to activate and specifically use the patient's resources.'' Therapeutic alliance is seen as a specific resource within the psychotherapy situation. For patients, an exemplary item on this scale was ''Today I felt comfortable in the relationship with the therapist.'' Most items were negatively labeled, as, for example, ''I believe that the therapist could attend more to my feelings.'' For therapists, items included statements like ''Today I felt comfortable in the relationship with the patient.'' The postsession reports for both patient and therapist included a scale for felt therapeutic progress. The patient postsession report also included items for corrective experiences and self-efficacy.
Statistics
Statistical analysis was performed using parametric methods for comparisons of independent and dependent samples. To identify time trends in adherence as measured by medication event-monitoring system, we calculated a slope for each patient using linear regression. We then tested whether adherence slopes for patients from the intervention and control groups differed from each other (analysis of variance repeated measurement design). We used correlations as a measure of association. Additionally, reliability scores for the process scales were calculated separately for HIV participants and outpatient psychotherapy participants (see Table I ). To improve reliability, patient and therapist perspectives were taken together. Means and standard deviations reflect the combined perspective in Table I .
Results
Effects of Psychological Intervention
Of the 23 persons in the psychotherapy treatment group who completed psychotherapeutic treatment, 16 maintained initial high medication adherence. In the control group, only five of 24 maintained initial high adherence.
Apart from the positive effect of psychotherapy on adherence (see Weber et al., 2004) , a major effect on changes of experience and behavior, such as feeling more confident and relaxed, more optimism, and a better sense of coming to terms with their problems, F(1, 53)06.81, p 0.01, was found. Moreover, the total score of changes of experience and behavior correlated significantly with adherence slope (r 0 0.29, pB.05), and participants with better adherence improved more reliably in experience and behavior. Participants with 10 or more cognitive behavior interventions experienced more improvement; these results were presented and discussed in Weber et al. (2004) . A comparison of the two median-split groups (improved adherence and not improved adherence) revealed a significant difference between them, F(1, 38) 09.16, p B.01. Table II shows the productÁmoment correlations between changes of experience and behavior and measures of process such as therapeutic alliance, activation of resources, and clarification of meaning. For this purpose, the process measures have been averaged over the entire course of each individual treatment. Therefore, the correlations in Table II do not show process over time but global association with changes of experience and behavior. These correlations in the table suggest that the associations between process variables and variables of microoutcome strengthen over the course of treatment with the global outcome, as measured with the VEV. However, this is not the case for some process variables. The strongest effect is on corrective experiences, a clear measure of micro-outcome.
Psychotherapy Process in the HIV Psychotherapy Group
Our main hypothesis was that participants of the psychotherapy treatment group, who experienced more improvement in adherence and changes of experience and behavior, would also show higher levels of involvement in therapeutic process, as measured by the four process variables. Accordingly, we median-split the psychotherapy group sample by high versus low changes of experience and behavior (low VEV and high VEV) at the end of therapy into not improved (low VEV) and improved (high VEV) and tested against the course of the process variables. The course of the psychotherapy was aggregated into three phases, following Howard and others (Howard, Orlinsky, & Lueger, 1994; Hill & Lambert, 2004) . This was necessary because of the large differences in treatment length and number of sessions. As a Note. Means and standard deviations are calculated for z-transformed data to obtain the same metric for the two samples (pooled sample from all measurements). The variables corrective experiences and self-efficacy were scales of the patient postsession report, so only the patient's perspective is represented by these variables. The other process variables are combined values of therapist and patient perspectives. Psychotherapy and adherence to anti-HIV therapy 207 baseline for each patient, we used the values of the first session. Therapeutic alliance did not differ between the improved and not-improved groups, and there was no effect for course or interaction between course and group for therapeutic alliance. Activation of resources tended to separate the two outcome groups, F(1, 25) 03.30, pB.10, h 2 0.12, but there was no effect for course or any interaction between groups and time course. For clarification of meaning, there was a tendency for an effect between groups, F(1, 25)02.74, p 0.11, h 2 0.10, and for an effect of time course, F(1, 25) 03.90, p B.10, partial h 2 0.14, indicating a negative slope toward the end of therapy in both groups. For mastery/coping, there was no main effect between the two groups but a trend for a statistical interaction between time course and VEV outcome, F(1, 25) 03.51, p B.10, partial h 2 0.12. The latter indicated that the HIV patients who gained more in the psychotherapeutic treatment improved in mastery/coping, as seen by both themselves and therapists, in contrast to the not-improved group. For problem actuation, we found no differences between the two groups.
Micro-outcomes (i.e., corrective experiences and self-efficacy, as reported by the patient, and progress in therapy, as rated by patients and therapists) also separated the two groups, indicating that patients and therapists were good judges of the ongoing process. For corrective experience, this effect was highly significant between the improved and not-improved groups, F(1, 25) 08.23, p B.01, partial h 2 0.25, and there was an additional interaction effect between the outcome groups and time course, F(1, 25) 03.29, p B.01, partial h 2 0.12. Progress in therapy also separated the two groups, F(1, 25) 06.16, p B.05, partial h 2 0.20. There was an expected interaction tendency in that persons in the improved outcome group also reported more self-efficacy in the course of the psychotherapeutic intervention, F(1, 25) 02.77, p B.10, partial h 2 0.10. Figure 1 (AÁD) shows the reported effects between the two outcome groups of HIV-infected persons in the four proposed process variables.
Comparison of HIV Psychotherapy and General Psychotherapy Groups
A comparison of psychological outcome measures confirmed two effects: Patients in the general psychotherapy group (a) were initially more distressed, as measured with the SCL-90-R GSI, and (b) reached higher levels of effect (preÁpost) compared with those in the HIV psychotherapy group.
The outpatient group completed the same postsession reports as the main study group, and we felt that we could compare the process variables. However, it should be noted that the average duration of therapy for the outpatient group was more than 30 sessions compared with 13 sessions for the HIVinfected group.
We hypothesized that in self-referred psychotherapy (the outpatient clinic group) the mechanisms of change would be more pronounced and result in greater change. In Table III , group comparisons for the five mechanisms of change (counting therapeutic alliance) and the three micro-outcomes (progress in therapy, corrective experiences, and self-efficacy) are given.
Figure 2 (AÁD) depicts the averaged phases in the four process variables for the main and comparison groups. Although all differences were in the predicted direction, the effect on problem actuation was larger than expected. There were no differences between the two groups in terms of resource activation and therapeutic alliance. The differences between the two groups over the course of treatment included the first session (baseline), with the exception of clarification of meaning, for which there was one significant interaction (Group)Time Course). Again, the direction of the effect was as expected: Over the course of treatment, outpatients choosing psychotherapy reported more clarification of meaning than those randomly assigned to psychotherapy in the main study group.
Discussion
We studied the relationship between adherence and change of experience and behavior. Furthermore, we were interested in the postulated mechanisms of change and outcome in HIV-infected patients during psychotherapy. We hypothesized that adherence and change of experience are related. We observed that the change of experience and behavior was associated with improved adherence. Therefore, psychotherapy might be a beneficial intervention for HIV-infected persons undergoing a challenging drug treatment. This result enhances and builds upon the finding of Weber et al. (2004) of a significant relationship between adherence and psychotherapy. Furthermore, members of the HIV psychotherapy group reported greater improvement in their mental health and behavior during the study period than did members of the HIV control group. This improvement correlated with number of sessions (i.e., patients having 10 or more consultations with a psychotherapist reported more improvement than those who had fewer). The cost of the additional intervention approximates the cost of 1 month of the standard triple-antiviral regimen (Weber et al., 2004 ).
More specifically, we hypothesized that HIV-infected patients with improvements in adherence and changes of experience and behavior show higher levels of involvement in therapeutic process. We observed that almost all proposed mechanisms of therapy such as mastery/coping, clarification, resource activation, and therapeutic alliance correlated with both medication adherence and perceived improvement in mental health and behavior. However, detailed results of involvement in therapeutic process measured by four process variables*therapeutic alliance, activation of resources, clarification of meaning, and mastery/coping*were rather inconsistent. When the intervention group was separated into those who perceived high mental health and behavior benefit (improved group) and those who perceived low benefit (not improved), analysis suggests that the former were more deeply involved in the psychotherapeutic process and, therefore, benefited from higher levels of the proposed mechanisms of change. This effect could not be attributed to therapeutic alliance: Patients and therapists of both the improved and the not-improved groups rated the quality of the therapeutic alliance at about the same level. As a result of relatively small sample sizes, it must be considered that results could reflect a Type II error (b error). Additionally, the exploratory approach in this study has to be considered. Nonsignificant findings should not be interpreted because of weak power, whereas significance might be effected by exploratory multiple testing and, therefore, should be interpreted with caution.
Furthermore, in comparing the HIV-infected psychotherapy group and an outpatient clinic group of individuals with self-referred psychotherapy, we hypothesized that mechanisms of change would be more pronounced and result in greater change in the latter. We observed that the two groups did not differ in basic ingredients of psychotherapeutic change such as therapeutic alliance and activation of resources in contrast to problem actuation. These results seem to indicate an important message: In order to change patterns of problematic behavior and experience, problems have to be activated. Hence, Figure 1 . (AÁD) The z-transformed scores of four process variables for the HIV psychotherapy group in the randomized trial median-split with high and low changes in experience and behavior (Veränderungsfragebogen des Erlebens und Verhaltens). The first session is the baseline; the three phases are average scores for sessions in the beginning, middle, and end phases of therapy.
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Adherence to medication is an immense task: Not only must one swallow many pills a day (often more than 10), but some of these pills have to be refrigerated, some taken before meals, some after, and some at regular times each day. An HIV-positive person often has other difficulties as well (Folkman, 1997) , such as facing the illness and death of loved ones. Results of our study suggest that supportive intervention, especially clarification of meaning, can improve quality of life for HIV-infected persons. By helping patients focus on new relations and new perspectives, therapists can actively turn ''lead into gold'' (Taylor & Brown, 1988) , installing a positive feedback loop that helps them maintain good humor, high self-esteem, and good affect regulation. In particular, an intervention based on cognitiveÁ behavioral techniques seems to help HIV-infected persons maintain high medication adherence.
Limitations
To our knowledge, this is the first study to assess the process of behavioral change in a randomized controlled trial involving HIV-infected persons. The change aimed for was maintaining medication adherence, which limits the cognitiveÁbehavioral intervention to a single problem. The randomized design did not account for clinical considerations or the individual needs of patients. However, participants in the intervention arm were free to quit the additional treatment as they wished. The average number of sessions was relatively low considering that patients were not charged for therapy (weekly individual sessions) and were free to discuss further personal problems in addition to adherence. However, nobody quit, and some patients attended the maximum number of sessions.
The relatively large range of participation in the intervention group posed problems in terms of process research. We followed a rather simple rule, dividing all interventions into three parts or phases: beginning, middle, and end of psychological intervention. Another difficulty was assessment of process variables. There is a large and still growing body of literature concerning the question of the processÁ outcome relationship in psychotherapy (Orlinsky, Rønnestad, & Willutzki, 2004) . We solved this problem by using a theory-driven measurement of postsession reports completed both by therapist and patient to obtain reliable scales of clinically relevant psychotherapy process variables (Lambert & Ogles, 2004). Orlinsky and Howard (1978) have stressed the importance of an experiential perspective on the events of therapy. By using self-report, we emphasize the experience of both patients and therapists rather than ''objective'' observer criteria. The postsession report used in this study had been revised several times, gradually integrating scales for change mechanisms (Grawe, 2004b) . We focused on mastery/coping, clarification of meaning, and problem actuation as mechanisms of change. Arguably, other variables are also involved in psychotherapy, such as emotional regulation mechanisms (Mergenthaler, 1996; Znoj, Nick, & Grawe, 2004) , motivational processes (Jeger, Znoj, & Grawe, 2003; Schulte, Hartung, & Wilke, 1997; Znoj et al., 2000) , and cognitive processes such as assimilation of problematic experiences (Stiles, 2002) .
The method of measuring mechanisms of change used here has the advantage of not requiring great research investment; combining the perspectives of patient and therapist creates relative objectivity. The process variables in this study have theoretically been linked to the outcome (Grawe, 2004a) , but it is unclear to what extent these process variables might influence each other. There is a strong body of evidence that these variables are not independent. For instance, Gassmann (2002) showed that a strong focus on problem activation without resource activation leads to an impaired session outcome and that the interplay between these two variables is important for the outcome of psychotherapy. Our focus in this study was mainly to show that the postulated process variables are linked to the outcome. The results in the primary study, which showed differential use of change mechanisms, were confirmed in the comparison study. Most interestingly, the so-called basic requirements of psychotherapy* working alliance and resource activation*were not observed to differ in the two studies. We focused on change of experience and behavior (VEV) as the main outcome measure because the HIV treatment group showed very low signs of psychological disturbances Psychotherapy and adherence to anti-HIV therapy 211 as rated by the SCL-90-R. This fact limits the possible improvements resulting from psychological interventions.
In the first analysis there was a trend indicating that the improved subgroup of HIV-infected persons experienced more resource activation during the sessions; however, in contrast to our assumptions, in the HIV intervention group problem actuation was not related to outcome. This could be due to the relatively low psychological distress of the HIVinfected persons in this study. In fact, the GSI for participants in this study was even lower than in a normative sample of HIV-infected men . This might be a result of the highly effective medication treatment administered to participants in the present study. It is important to stress that all participants in the study were selected randomly (Weber et al., 2004) .
A limitation of this study concerns the manipulation check and treatment in general. There was no systematic manipulation check in this study. However, all therapists of the HIV intervention group were supervised in terms of the main treatment goals, namely improvement of the adherence to medical therapy. The small sample size of the HIV intervention group and the post hoc approach that was followed in this research reduce the power of the presented analyses and the generalizability of the results. To our knowledge, this is the first study regarding processÁoutcome research in HIV patients. Therefore, an exploratory approach was appropriate. Although many of the contrasts do not reach statistic significance, the given effect sizes show that this might be due to lack of statistical power. The results of this study have to be reproduced in larger samples and in a priori research designs.
Open Questions and Future Research
The psychotherapists in this study received no instruction aside from a lecture on HIV treatment and a mandate to focus on adherence. This leaves room for improvements; for instance, more focused interventions, enhanced support, or focus on positive states of mind (Gonzalez et al., 2004 ) might improve effectiveness. Some individuals may need clarification of motives, fears, or a grief-related topic; others lack social support; and still others lack specific skills for maintaining medication adherence. So far, studies comparing group versus individual interventions and the various interventions for groups are lacking.
We hope that this study's focus on process will lead to more investigations of topics related to adherence. Referral to mental health specialists is a possible tool for maintaining medication adherence for people infected with HIV. Further, policymakers should note that individual psychological intervention is inexpensive compared with treating the medical consequences of nonadherence.
